Ganoderic acid Mh
IUPAC name: (E)-5-acetoxy-6-(3-acetoxy-7,15-dihydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-methyl-hept-2-enoic acid
CAS Number: 110024-17-4
Class: Terpenoid
Mushrooms contain this compound
1 mushrooms
| MushID |
Thai name |
Common name |
Scientific name |
Family |
| 1 |
เห็ดหลินจือ |
Lingzhi |
Ganoderma lucidum ( Curtis ) P. Karst. |
Ganodermataceae |
2D Structure
Compound Properties
SMILES
CC(=O)OC(C(C1CC(C2(C1(C)CCC1=C2C(O)CC2C1(C)CCC(C2(C)C)OC(=O)C)C)O)C)C/C=C(/C(=O)O)\C
Physicochemical Properties
| Formula |
C34H52O8 |
| Molecular wieght(g/mol) |
588.77 |
| Num. of Heavy atoms |
42 |
| Num. of Aromatic Heavy atoms |
0 |
| Fraction Csp3 |
0.79 |
| Num. of Rotatable bonds |
9 |
| Num. of H-bond acceptors |
8 |
| Num. of H-bonds donors |
3 |
| Molar Refractivity |
161.77 |
| TPSA (square Angstrom) |
130.36 |
Lipophilicity
| iLOGP |
3.97 |
| XLOGP3 |
4.96 |
| WLOGP |
5.60 |
| MLOGP |
3.84 |
| Silicos-IT LOGP |
5.30 |
| Consensus LOGP |
4.73 |
Water Solubility
| ESOL |
|
| LogS |
-6.02 |
Solubility(mg/ml) |
5.61E-04 |
Solubility(mol/l) |
9.52E-07 |
Class |
Poorly soluble |
| Ali |
|
| LogS |
-7.44 |
Solubility(mg/ml) |
2.16E-05 |
Solubility(mol/l) |
3.67E-08 |
Class |
Poorly soluble |
| Silicos-IT |
|
| LogS |
-4.76 |
Solubility(mg/ml) |
1.03E-02 |
Solubility(mol/l) |
1.74E-05 |
Class |
Moderately soluble |
Pharmacokinetics
| GI absorbtion |
Low |
| BBB permeant |
No |
| Pgp substrate |
Yes |
| CYP1A2 inhibitor |
No |
| CYP2C19 inhibitor |
No |
| CYP2C9 inhibitor |
No |
| CYP2D6 inhibitor |
No |
| CYP3A4 inhibitor |
Yes |
| Log Kp (skin permeation) (cm/s) |
-6.37 |
Druglikeness
| Lipinski Num. violations |
1 |
| Ghose Num. violations |
3 |
| Veber Num. violations |
0 |
| Egan Num. violations |
0 |
| Muegge Num. violations |
0 |
| Bioavailability Score |
0.56 |
Medicinal Chemistry
| PAINS Num. of alerts |
0 |
| Brenk Num. of alerts |
3 |
| Leadlikeness Num. of violations |
3 |
| Synthetic Accessibility |
6.94 |
Biological Activity
| Biological Activity |
JID |
| Anticancer |
9 |
